Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock-Reference-Cited by-同舟云学术

Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock

Published:2016-06 Issue:6 Volume:44 Page:1365-1378
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Voss Oliver H.,Murakami Yousuke,Pena Mirna Y.,Lee Ha-Na,Tian Linjie,Margulies David H.,Street Jonathan M.,Yuen Peter S.T.,Qi Chen-Feng,Krzewski Konrad,Coligan John E.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference41 articles.

1. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14;Akashi;J. Exp. Med.,2003

2. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells;Banerjee;Proc. Natl. Acad. Sci. USA,2006

3. The CD300 molecules: an emerging family of regulators of the immune system;Borrego;Blood,2013

4. TREM-1 amplifies inflammation and is a crucial mediator of septic shock;Bouchon;Nature,2001

5. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms;Chanteux;Respir. Res.,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD300f immune receptor is a microglial tissue damage sensor and regulates efferocytosis after brain damage;2024-09-10

2. Pathogenic rickettsiae utilize the phosphatidylserine binding receptor CD300f on macrophages for host invasion and pathogenesis;2024-05-10

3. CD300e: Emerging role and mechanism as an immune-activating receptor;International Immunopharmacology;2024-05

4. Porous Microspheres as Pathogen Traps for Sepsis Therapy: Capturing Active Pathogens and Alleviating Inflammatory Reactions;ACS Applied Materials & Interfaces;2024-04-29

5. NF-κB in biology and targeted therapy: new insights and translational implications;Signal Transduction and Targeted Therapy;2024-03-04